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Abstract  
Febrile seizures (FS) are the most common seizure type in children. Recurrent FS are a 
risk factor for developing temporal lobe epilepsy later in life and are known to have a 
strong genetic component. Experimental FS (eFS) can be elicited in mice by warm-air 
induced hyperthermia. We used this model to screen the chromosome substitution strain 
(CSS) panel derived from C57BL/6J and A/J for FS susceptibility and identified 
C57BL/6J-Chr2A/NaJ (CSS2), as the strain with the strongest FS susceptibility 
phenotype. The aim of this study was to map FS susceptibility loci and select candidate 
genes on mouse chromosome 2.  
We generated an F2 population by intercrossing the hybrids (F1) that were 
derived from CSS2 and C57BL/6J mice. All CSS2-F2 individuals were genotyped and 
phenotyped for eFS susceptibility, and QTL analysis was performed. Candidate gene 
selection was based on bioinformatics analyses and differential brain expression 
between CSS2 and C57BL/6J strains determined by microarray analysis. 
Genetic mapping of the eFS susceptibility trait identified two significant loci: FS-
QTL2a (LOD-score 3.6) and FS-QTL2b (LOD-score 6.2). FS-QTL2a contained 44 genes 
expressed in the brain at post natal day 14. Four of these (Arl6ip6, Cytip, Fmnl2  Ifih1) 
contained a non-synonymous SNP comparing CSS2 and C57BL/6J, six genes (March7, 
Nr4a2, Gpd2, Grb14, Scn1a, Scn3a) were differentially expressed between these 
strains.  A region within FS-QTL2a is homologous to the human FEB3 locus. The fact 
that we identify mouse FS-QTL2a with high FEB3 homology is strong support for the 
validity of the eFS mouse model to study genetics of human FS.  
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Introduction 
Approximately 2-5% of the North-American and European children suffer from febrile 
seizures (FS) and thereby FS are the most common type of seizures during childhood 
(Hauser, 1994). FS have a peak occurrence between 6 months and 5 years of age and 
can be characterized as either simple or complex. Simple FS are usually benign, non-
recurring seizures, lasting shorter than fifteen minutes, whereas complex FS are 
characterized by duration of more than fifteen minutes or recurrence within 24 hours. 
Complex FS are an important risk factor for the development of mesial temporal lobe 
epilepsy (mTLE) later in life (French et al., 1993). 
Family, twin and association studies indicate a strong genetic component in FS 
susceptibility. In twins, the concordance rate was higher in monozygotic (36%) than in 
dizygotic twins (12%) (Kjeldsen et al., 2002). Human linkage studies identified several 
loci for familial FS (Nakayama, 2009). In addition, mutations in several genes coding for 
voltage-gated sodium channel subunits (SCN1A, SCN2A and SCN1B) and a GABA(A) 
receptor subunit (GABRG2) were identified in families suffering from generalized 
epilepsy with FS plus (GEFS+) (Hirose et al., 2003). Common forms of FS are 
considered to be genetically complex disorders, involving multiple susceptibility genes. 
So far, association studies have implicated only a limited number of genes for sporadic 
FS, including IL1B (Kira et al., 2005), IL10 (Ishizaki et al., 2009), SCN1A (Chou et al., 
2003; Feenstra et al., 2014), GABRG2 (Chou et al., 2003) and CHRNA4 (Chou et al., 
2003). However, the strength of several of these associations has been debated, since it 
has proven difficult to replicate associations (Nakayama, 2009). Therefore, new genetic 
strategies are required to identify genes involved in FS susceptibility.  
Recently, we employed a forward genetic strategy to search for FS susceptibility 
genes, combining a mouse model for experimental FS (eFS) with QTL (quantitative trait 
locus) mapping. Baram and colleagues have previously shown that eFS can be induced 
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in rat pups by hyperthermia (Baram et al., 1997). We adapted this eFS model to mouse 
(van Gassen et al., 2008) and performed video/EEG monitoring to validate the mouse 
model and to subsequently use it as a phenotypic screen to study genetics of eFS 
susceptibility in inbred strains (Hessel et al., 2009). As a first step in identifying eFS 
QTLs, we screened a mouse chromosome substitution strain (CSS, also called 
consomic strain or line) panel derived from C57BL/6J (host strain) and A/J (donor strain) 
(C57BL/6J-Chr #A/NaJ), a powerful tool to dissect complex genetic traits (Nadeau et al., 
2000). We identified six chromosomes carrying putative QTLs for eFS susceptibility and 
found one of the most significant susceptibility phenotype on mouse chromosome 2 
(Hessel et al., 2009). In humans, several genes previously associated with FS are 
located on chromosome 2 (for review see (Nakayama, 2009)), including IL1β, and 
SCN1A and SCN2A in the FEB3 (2q24) locus. 
The aim of this study was to map eFS susceptibility QTLs on mouse 
chromosome 2 and identify candidate genes. We have successfully used this strategy to 
identify Srp9 as a new FS susceptibility gene on chromosome 1 (Hessel et al., 2014). 
Therefore, we generated an F2 population by intercrossing the hybrids (F1) between the 
consomic C57BL/6J-Chr 2A/NaJ (CSS2) and C57BL/6J host strains. After pheno- and 
genotyping the F2 progeny we performed QTL analysis and identified two highly 
significant QTLs for eFS susceptibility, one of which contains a sequence with high 
homology to the human FEB3 locus, coding for several subunits of the voltage-sensitive 
sodium channels, including Scn1a and Scn3a. 
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Material and Methods  
 
Animals 
Breeding pairs for C57BL6/J and C57BL/6J-Chr 2A/NaJ (CSS2) were obtained from The 
Jackson Laboratory (Bar Harbor, ME, USA). To produce F1 hybrids, C57BL/6J and 
CSS2 males and females were reciprocally crossed. F1 hybrids were then intercrossed 
producing 143 F2 progeny (61 mice - male: female = 25 : 36 - originated from CSS2 
mothers and 82 - male : female = 52 : 30 - from C57BL/6J mothers).  
Animals were kept in a controlled 12 hour light-dark cycle (lights on: 7:00 a.m. to 7:00 
p.m.) with a room temperature of 22 ± 1ºC and a humidity of 50-70%. Food (Special Diet 
Services, Essex, England) and water were available ad libitum. All animals were housed 
in wire topped (Macrolon© Type II cages (Techniplast, Milan, Italy) with sawdust bedding 
and a paper tissue for nest building. Animals were killed by cervical dislocation or 
decapitation. All experiments were performed according to the institutional guidelines of 
the University Medical Center Utrecht (Current allowance number: 2012.I.03.047). The 
principles outlined in the ARRIVE guidelines and the Basel declaration, including the 3R 
concept, have been considered when planning the experiments. 
 
Phenotypic screen for eFS susceptibility.  
FS susceptibility in inbred mice was measured as described earlier.12 Prolonged eFS 
were elicited by exposing 14-day-old mice (P14) to a warm-air stream to induce 
hyperthermia. Susceptibility to eFS was determined by measuring the latency to tonic-
clonic seizures (febrile seizure latency = FSL), a phenotypic parameter which has 
previously been validated by video/EEG monitoring (Hessel et al., 2009). On P1, litters 
were culled to 4-6 pups with a balanced male: female ratio, when possible. On P10, a 
temperature sensitive transponder (IPTT-300, (BioMedic Data Systems) Plexx BV, Elst, 
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The Netherlands) was injected subcutaneously (separation time from the mother < 2 
min) in pups weighing > 5.0 g. At P14, individual pups were exposed to a pre-heated 
warm-air stream of 50 ± 0.5 ºC until they developed FS. Core body temperature was 
measured with a wireless temperature reader (WRS-6007, BioMedic Data Systems, 
Plexx BV) throughout the experiment. Mice were immediately sacrificed after 
hyperthermia and tails were collected for genotyping. All experiments were performed 
between 10:00 a.m. – 4:00 p.m. FSL of the complete CSS2-F2 progeny was determined 
within a period of two months.  
 
Genotyping and genetic map construction 
DNA was isolated from tails as described (Kas et al., 2009). DNA concentration was 
measured on agarose gel and samples were diluted to 10 ng/μl.  To generate a genetic 
map seventeen DNA markers (fifteen microsatellites and two SNPs) distributed over 
chromosome 2 were chosen from the mouse genome database based on the presence 
of allelic differences between the A/J and C57BL/6J inbred strains (Mouse Genome 
Informatics, http://www.informatics.jax.org). Microsatellite marker genotyping was 
performed by PCR. Primers (150 nM forward/reverse) flanking these markers 
(supplementary Table 1) (Sigma-Aldrich, Zwijndrecht, the Netherlands) were used to 
amplify the DNA (50 μg/reaction) in a Veriti 96 wells thermocycler (PCR system, Applied 
Bioscience Inc., Foster city, CA, USA) using Super Taq polymerase (SphaeroQ, 
Gorinchem, The Netherlands: 0.25 units/reaction). The PCR products were separated on 
3% agarose gels and visualized by ethidium bromide staining. Two additional TaqMan 
SNP primers were used. SNP genotyping was performed as described (Kas et al., 
2009). The two SNP markers were selected using Genenetwork 
(http://www.genenetwork.org/): rs27498297 and rs27434812. Primers (Taqman SNP 
genotyping Assay, Applied Biosystems, USA) were used to amplify the DNA (10 
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ng/reaction) using TaqMan Universal PCR Master Mix (Applied Biosystems, USA). SNP 
analyses were done with a sequence detection system (7900HT, Applied Biosystems, 
Foster City, CA, USA (Kas et al., 2009). Segregation ratios of the genotypes of individual 
markers were checked by means of the Chi-squared goodness-of-fit-test. None of the 
markers showed (P < 0.05) segregation distortion (AA:AB:BB ratio 1:2:1). Marker 
positions (in sex-averaged cM) were taken from the revised genetic map for improved 
QTL mapping (Cox et al., 2009) by using the ‘mouse map converter’ 
(http://cgd.jax.org/mousemapconverter/).  
 
QTL mapping  
The Kolmogorov-Smirnov one sample test was used to check Gaussianity of eFS 
susceptibility in the F2 population. Because this parameter was not normally distributed, 
the trait was logarithmically transformed prior to QTL analysis. The location of the 
(transformed) eFS susceptibility QTLs and the variance explained by each locus were 
determined by using the parametric interval mapping approach from the MapQTL® 
software package, version 4.0. Results were expressed as LOD scores. LOD score 
threshold (confidence level 0.05) was determined using 10,000 random permutations 
(random shuffling of genotypes with phenotypes), yielding a threshold LOD score value 
of 2.39 for FSL. Thus, an association was assumed significant when the LOD score was 
≥ 2.39. Cosegregation of the phenotype with alleles at a marker locus was evaluated by 
one-way analysis of variance (ANOVA). All data within genotype groups were normally 
distributed (Kolmogorov-Smirnov one sample test). In the ANOVA tests, homogeneity of 
variance was tested (Levene’s test). For each marker the data were homoscedastic.  
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Candidate gene selection 
The confidence interval (in bp) for the QTL was determined using the “LOD drop-off” 
method where minus 1 LOD support interval is constructed by taking the two positions 
left and right of the maximum value in the LOD profile that have an LOD value of 1 less 
than this maximum; the two positions are estimated using linear interpolation 
calculations. Coordinates were obtained with NCBI Build 37 (Blake et al., 2009). Genes 
(i.e. protein coding genes and non-coding RNA genes) present in the 1-LOD support 
interval were selected on http://www.informatics.jax.org/. Brain expressed genes were 
selected based on microarray analysis of P14 mouse brain samples (see below). Genes 
on HSA2 (human chromosome 2) previously implicated in human FS or epilepsy were 
studied using OMIM http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM, CarpeDB 
http://www.carpedb.ua.edu/  or Egad http://www.epigad.org/egad/list. (non-synonymous) 
SNP differences between A/J and C57BL/6J were studied with Mouse Genome 
Database (http://www.informatics.jax.org/strains_SNPs.shtml). The selected non-
synonymous SNP differences between A/J and C57BL/6J were analysed with Polyphen 2 
and SIFT programs to determined whether they are missense or nonsense mutations. 
Other QTLs and eQTLs mapped in this region were studied with the Mouse Genome 
Database (http://www.informatics.jax.org/) 
 
Microarray gene expression analysis 
Total RNA was isolated from P14 C57BL/6J (n = 4) and CSS2 (n = 4) brains. These 
were compared in a common reference experiment design using 8 dual channel 
microarrays with each sample hybridized against an identical common reference total 
RNA sample consisting of pooled total RNA from the four C57BL/6J samples. Within 
each group of four microarrays for each genotype, sample versus common reference 
hybridisations were performed in balanced dye-swap. The microarrays used were 
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mouse whole genome GE 4x44K v2 (Agilent, Belgium) representing 39429 M. musculus 
60-mer probes in a 4x44K layout. cDNA synthesis, cRNA amplification, labeling, 
quantification, quality control and fragmentation were performed with an automated 
system (Caliper Life Sciences NV/SA, Belgium), starting with 3 ug total RNA from each 
sample, all as previously described in detail (van Wageningen et al., 2010). Microarray 
hybridization and washing was with a HS4800PRO system with QuadChambers (Tecan, 
Benelux) using 1000 ng, 1-2% Cy5/Cy3 labeled cRNA per channel as described (van 
Wageningen et al., 2010). Slides were scanned on an Agilent G2565BA scanner at 
100% laser power, 30% PMT. After automated data extraction using Imagene 8.0 
(BioDiscovery), Loess normalization was performed on mean spot-intensities (Yang et 
al., 2002). Gene-specific dye bias was corrected by a within-set estimate. Data were 
further analysed by MAANOVA (Wu et al., 2003) modeling sample, array and dye effects 
in a fixed effect analysis. The P-values were determined by a permutation F2-test, in 
which residuals were shuffled 10000 times globally. Gene probes with P < 0.05 after 
false discovery rate determination (FDR by Benjamini-Hochberg) were considered 
significantly changed. In cases of multiple probes per gene, the values from the most 3' 
probe were used. Prediction of brain expression was based on A-values. For genes with 
A-values < 7.0 brain expression could not reliably be determined (these genes are 
marked * in table 2). 
 
Statistical analyses  
All statistical analyses were carried out according to Field (Field, 2009) using a IBM© 
SPSS® Statistics for MS Windows (version 20.0) computer program (IBM Nederland 
N.V., Amsterdam, The Netherlands), and paying attention to the assumptions that 
underlie the various statistical procedures. Two-sided, exact (i.e. for the nonparametric 
tests) probabilities were estimated throughout. The data were summarized by means 
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and standard error of the means (SEM). The Kolmogorov-Smirnov one-sample test was 
used to check Gaussianity of the data. 
The phenotypic characteristics of C57BL/6J and CSS2 mice were normally distributed 
and subjected to a two-way ANOVA with strain and gender as main factors. 
Homoscedasticity was tested using the Levene’s test, which is a powerful and robust 
test based on the F statistic. If the ANOVA showed significant effects the group means 
were further compared with the unpaired Student’s t test. The unpaired Student’s t tests 
were performed using pooled (for equal variances) or separate (for unequal variances) 
variance estimates. Temperature increase was analysed with a univariate repeated 
measures two-way ANOVA and Bonferroni posthoc test was performed if allowed. The 
choice of a univariate instead of a multivariate statistic in the repeated measures 
ANOVA is based on the criteria given by Algina and Keselman (Algina & Keselman, 
1997). In case of univariate repeated measures ANOVA violations to sphericity were 
addressed with a Huynh-Feldt correction to degrees of freedom. The equality of 
variances was tested with the Levene’s test. For the unpaired Student’s t test with 
separate variance estimates, SPSS® uses the Welch-Satterthwaite correction. 
Performing many ANOVA’s in the F2 population (see QTL analyses) increases the risk of 
a Type I error. To avoid this, the level of statistical significance for these ANOVA’s was 
adjusted by using the so-called Dunn—Šidák method (α = 1 – [1 – 0.05]1/ γ; γ = total 
number of DNA markers [17, α ≈ 0.003]). In all other cases (i.e. the Kolmogorov-Smirnov 
one sample test, Levene’s test, statistical testing of host and consomic strain, Chi-
squared goodness-of-fit-test) the probability of a Type I error < 0.05 was taken as the 
criterion of significance. 
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Results: 
 
Comparison of FS susceptibility in C57BL/6J and CSS2 
The difference in FSL between CSS2 (445.1 ± 15.1 s) and C57BL/6J  (597.4 ± 36.2 s) 
mice (Fig.1 panel A) was confirmed in a separate group of male and female CSS2 (n = 
9,) and C57BL/6J (n = 9) (two-way ANOVA: strain effect, Fstrain(1,14) = 11.867, P = 0.0001; 
gender effect, Fgender(1,14) = 0.298, P = 0.594; interaction effect, Finteraction(1,14) = 0.008, P = 
0.929). The time-course of body temperature increase during exposure to hyperthermia 
did not differ between C57BL/6J and CSS2 mice (Fig. 1, panel B); time F(1,14) = 1704.63, 
P = 0.0001; time×group F(1,14) = 1.363, P = 0.264). There was neither a difference in P14 
body weight between the C57BL/6J (7.36 ± 0.24 g) and CSS2 (7.07 ± 0.13 g) (two-way 
ANOVA: strain effect, Fstrain(1,14) = 3.091, P = 0.101; gender effect, Fgender(1,14) = 0.439, P = 
0.518; interaction effect, Finteraction(1,14) = 1.137, P = 0.304) nor a difference in core-body 
temperature at the start of the hyperthermia induction between the C57BL/6J (T start = 
36.0 ± 0.1°C) and CSS2 (T start = 35.9 ± 0.2 °C) (two-way ANOVA: strain effect, Fstrain(1,14) 
= 0.202, P = 0.660; gender effect, Fgender(1,14) = 1.153, P = 0.301; interaction effect, 
Finteraction(1,14) = 2.502, P = 0.136) 
 
QTL analysis CSS2 
To map the QTLs for eFS susceptibility on mouse chromosome 2, we bred a CSS2-F2 
generation (n = 143) by intercrossing the hybrids (F1) between the CSS2 and C57BL/6J 
inbred strains. As expected, phenotyping these genetically unique F2 mice revealed a 
(left) shift toward a shorter FSL compared to C57BL/6J mice (Fig. 2A). Two QTLs were 
mapped on chromosome 2 (Fig. 2B). The most proximal FS-QTL2a had a LOD score of 
3.6, accounted for 13.8% of the F2 phenotypic variance and the effect was recessive with 
respect to the A/J grandparent’s allele (Table 1). The 1-LOD support interval of FS-
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QTL2a was 52,581,428 – 66,278,629 bp. FS-QTL2b had a LOD score of 6.2, accounted 
for 19.8% of the F2 phenotypic variance and the effect is additive for the A/J 
grandparent’s allele (Table 1). The 1 -LOD support interval for QTL2b was 114,875,854 
– 133,817,501 bp (Fig. 2B). Detailed analysis of FS-QTL2b will be described elsewhere 
(Hessel et al., submitted).  
 
FS-QTL2a 
The 1-LOD support interval of FS-QTL2a (52,581,428 – 66,278,629 bp) contains 53 
coding genes (and 47 predicted genes (GM)). Microarray analysis of brain tissue of 
C57BL/6J P14 mouse pups confirmed that 44 of these genes (and 8 GM genes) were  
brain expressed (Table 2). DNA microarray data has been submitted to GEO (accession 
nr GSE41320). During the review process the microarray data are available through the 
following link:  
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=hbwzjwcusywugtu&acc=GSE4132
0). In other mice studies no other QTLs related to epilepsy or other relevant 
(neurological) disorders were mapped in this QTL2A region.  
Candidate gene selection was based on differential expression and SNPs between 
CSS2 and C57BL/6J. Six brain expressed genes in FS-QTL2a showed differential 
expression between C57BL/6J and CSS2 at P14 (March7, Nr4a2, Gpd2, Grb14, Scn1a, 
Scn3a, (Table 2, genes in Bold)). Four brain expressed genes in the QTL contained a 
non-synonymous SNP that may affect protein function (Arl6ip6, Cytip, Fmnl2 and Ifih1 
(Table 2, genes underlined)).  All these non-synonymous SNPs resulted in a missense 
mutation by changing the amino acid of the protein and did not cause a nonsense 
mutation (premature stop codon).   Thus, based on expression difference and/or the 
presence of non-synonymous SNPs these 10 genes were designated candidate genes 
within FS-QTL2a.  Further analysis of FS-QTL2a revealed that Scn1a and Scn3a, genes 
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previously associated with epilepsy, are genes encoded in the human FEB3 locus. FS-
QTL2a contains a sequence which is highly homologous to the human FEB3 locus 
(2q23-q24 (Fig. 3), coding for several subunits of voltage gated sodium channels, some 
of which have previously been associated with human febrile or developmental seizures 
(Fig 3).  
 
Discussion 
In a forward genetic screen for eFS susceptibility using the C57BL/6J-Chr #A/NaJ CSS 
panel, we recently identified mouse chromosome 2 as the chromosome with the 
strongest eFS susceptibility phenotype) (Hessel et al., 2009). In the present study, we 
mapped two QTLs for eFS susceptibility on chromosome 2, FS-QTL2a and FS-QTL2b. 
Further analysis of FS-QTL2b will be described elsewhere (Hessel et al., submitted). 
The 1-LOD support interval of FS-QTL2a was 52,581,428 – 66,278,629 bp. This locus 
codes for 44 genes, which were confirmed to be expressed in brain tissue of P14 pups. 
Candidate gene selection identified 10 candidate genes, six based on differential brain 
expression (March7, Nr4a2, Gpd2, Grb14, Scn1a and Scn3a) and 4 genes containing a 
non-synonymous SNP that may affect protein function (Arl6ip6, Cytip, Fmnl2 and Ifih1) 
(see Table 2). The CSS2 strain, which is most susceptible to FS, showed reduced 
expression of March7, Nr4a2, Gpd2, Scn1a and Scn3 compared to the background 
strain C57BL/6J. March7, which showed the most significant reduction in expression, is 
a member of the MARCH family of membrane-bound E3 ubiquitin ligases (EC 6.3.2.19), 
which add ubiquitin to substrate proteins, thereby signaling their vesicular transport 
between membrane compartments (Bartee et al., 2004). Grb14 (growth factor receptor-
bound protein 14), which is the only candidate gene which showed increased expression 
in CSS2, encodes a growth factor receptor-binding protein that interacts with insulin 
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receptors and insulin-like growth-factor receptors, probably inhibiting receptor tyrosine 
kinase signaling (Daly et al., 1996).   
Only three (Scn1a, Scn3a and Nr4a2) of the ten candidate genes have previously been 
associated with epilepsy. Scn1a and Scn3a, coding for voltage dependent sodium 
channels, are located in a conserved region which is homologous to the human FEB3 
locus (Fig. 3, 2q23-24) (Peiffer et al., 1999) in which a SCN1A (Mantegazza et al., 2005) 
and a SCN9A gene mutation (Singh et al., 2009) were identified. SCN1A mutations 
(loss- or gain-of-function) have been detected in a variety of genetic epilepsy syndromes 
including several with FS as a prominent phenotype, such as GEFS+ and Dravet 
Syndrome (Mulley et al., 2005). Recent publications reviewing the identified gene 
mutations for SCN1A and their functions in animal and cell models emphasize the role of 
SCN1A in the susceptibility to different forms of epilepsy and febrile seizures (Brunklaus 
& Zuberi, 2014; Tang et al., 2014; Schutte et al., 2016). SCN3A mutations have not 
directly been associated with FS, but duplications in the SCN locus, which includes 
SCN3A but not SCN1A, have been associated with epilepsy in patients also suffering 
from FS (Vecchi et al., 2011). One SCN3A mutation has been associated with pediatric 
epilepsy (Holland et al., 2008). Recently, four novel SCN3A missense variants were 
identified in pediatric patients with focal epilepsy of unknown cause (Vanoye et al., 
2014).  The third gene previously linked to epilepsy is Nr4a2. Distribution of NURR1 (the 
human homologous of the Nr4a2 gene) positive cells was found to be altered in the 
cortex of temporal lobe epilepsy patients (Rossini et al., 2011). The other candidate 
genes in FS-QTL2a (March7, Arl6ip6, Cytip, Fmnl2, Gpd2, Grp14 and Ifih1) have not 
previously been associated with epilepsy.  
Based on our mouse differential expression data and above mentioned human studies 
Scn1a and Scn3a are strong candidate genes within FS-QTL2a. No non-synonymous 
SNPs were found between C57BL/6J and CSS2, indicating that Scn1a and/or Scn3a 
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expression levels, rather than protein (mal)function may be important in regulating FS 
susceptibility. For all ten candidate genes a potential causal relationship with FS 
susceptibility needs to be further investigated by performing, as recently described for 
the new FS susceptibility gene Srp9 (Hessel et al., 2014), for instance protein 
expression and functional interference studies in vivo and in vitro. It is important to 
realize that only candidate genes showing expression or haplotype/genotype differences 
between parental strains of the CSS can be detected with our approach. Moreover, 
using this CSS approach, we cannot rule out that cis or trans effects influence the results 
of our QTL mapping (Nadeau et al., 2000).        
Interestingly, previous seizure susceptibility mapping studies in mice, using chemically or 
electrically-induced seizure models, show that C57BL/6J mice, which are most 
susceptible to FS, are relatively resistant to seizures and seizure-induced cell death 
(Ferraro et al., 1995). This indicates that genes involved in FS susceptibility are distinct 
from those involved in chemical- or electrically-induced seizures. This notion is further 
substantiated by the fact that the only two other studies using the C57BL/6J-Chr #A/NaJ 
panel did not identify any seizure QTLs on chromosome 2, screening for susceptibility 
for sleep-related epilepsy (Strohl et al., 2007) or chemoconvulsant pilocarpine (Winawer 
et al., 2007). Mapping a mouse eFS QTL with homology to the human FEB3 locus is 
strong support for the validity of our forward genetic strategy in mouse to detect human 
FS genes. The mouse phenotypic screen is based on measuring the latency to eFS 
elicited by warm-air induced hyperthermia. Thus, in contrast to FS in children, eFS are 
elicited by hyperthermia without an underlying infection. In children vulnerable to FS, 
hyperthermia alone, for instance induced by a hot bath, may also cause FS (Fukuda et 
al., 1997). Thus, our data suggest that temperature sensitivity, rather than sensitivity to 
infection, is a key factor in the genetic predisposition to FS susceptibility. A recent study 
using a Dutch Cohort suffering from Dravet Syndrome with pathogenic SCN1A 
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mutations studied the events that trigger seizures in Dravet patients (Verbeek et al., 
2015). These authors identified elevated body temperature as an important seizure 
precipitant. The seizures could be caused by fever, a warm bath, ambient warmth, or 
physical exercise (Verbeek et al., 2015). 
In humans complex FS are a risk factor for the development of TLE later in life (French 
et al., 1993). Complex FS are associated with 30-70% of the adult TLE cases (French et 
al., 1993). Also, complex FS in rodents increase the risk to develop spontaneous 
recurrent seizures. Hyperthermia-induced FS elicit spontaneous recurrent seizures in 
35-50% of the animals (Dube et al., 2006; Koyama et al., 2012). One interpretation of 
these data is that complex FS and TLE share a common genetic predisposition.  Indeed, 
association and linkage studies have shown that the SCN1A  mutations are associated 
with TLE and FS susceptibility (Table 3) (Van Poppel et al., 2012; Kasperaviciute et al., 
2013). If FS and TLE indeed share a common genetic predisposition, candidate genes 
for FS susceptibility identified in the present study (such as Scn1a and Scn3a) may also 
be relevant for TLE.   
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Table 1. Co-segregation analysis of the CSS2-F2 progeny 
Febrile seizure latencies (FSL, s) are expressed as means (±SEM). Numbers in parentheses indicate number of mice. Some DNA 
samples failed to give a conclusive genotype, hence the number of mice typed varied slightly with each locus. Numbers in bold 
indicate significant difference (P < 0.003). Alleles: A = A/J-allel, B = C57BL/6J-allel. 
 
 
 
 
 
 
Table 2. Differential expression between C57BL/6J and CSS2 of brain expressed 
genes in FS-QTL2A. mRNA profiling of C57BL/6J (n = 4) and CSS2 (n = 4) mouse 
brains confirmed that 44 genes were brain expressed at P14 [and eight predicted (GM)] in 
FS-QTL2A. Six genes (in bold) were differentially expressed between strains (ratio 
CSS2/C57BL/6J, P-value for multiple testing P < 0.05). Four genes (underlined) contain 
non-synonymous SNPs (www.genenetwork.org). Candidate gene selection identified 10 
candidate genes, six based on differential brain expression [March7 (membrane 
associated ring finger 7), Nr4a2 (nuclear receptor subfamily 4, group A, member 2), 
Gpd2 (glycerol phosphate dehydrogenase 2, mitochondrial), Grp14, (growth factor 
receptor bound protein 14) Scn1a (sodium channel, voltage-gated, type I, alpha), and 
Scn3a (sodium channel, voltage-gated, type III, alpha)] and four genes containing a non-
synonymous SNP that may affect protein function [Arl6ip6 (ADP-ribosylation factor-like 
six interacting protein 6), Cytip (cytohesin 1 interacting protein), Fmnl2 (formin-like 2) 
and Ifih1 (interferon induced with helicase C domain 1)]. *A-value < 7: brain expression 
cannot be confirmed in our P14 microarray. 
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Table 3. Linkage and association studies in FS patients investigating genes 
in the FEB3 locus (http://www.epigad.org/egad/list). SCN3A is associated with 
pediatric epilepsies (Holland et al., 2008; Vanoye et al., 2014). 1 Schlachter et al. (2009); 
2 Le Gal et al. (2011); 3 Peiffer et al. (1999); 4 Mantegazza et al. (2005); 5 Zhang et al. 
(2010); 6 Chou et al. (2003); 7 Nakayama & Arinami (2006); 8 Berkovic et al. (2004) 9 
Sugawara et al. (2001); 10Singh et al. (2009). All SNPs in BOLD are missense SNPs. 
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Figure legends 
 
Fig 1. Febrile seizure susceptibility in C57BL/6J and CSS2 mice. (A) CSS2 mice (n = 9, 
445.1   15.1 s) have a shorter FSL (s) then C57BL/6J (n = 9, 597.4   36.2 s) Two-way 
ANOVA: strain effect, Fstrain(1,14) = 11.867, P = 0.0001; gender effect, Fgender(1,14) = 
0.298, P = 0.594; interaction effect, Finteraction (1,14) = 0.008, P = 0.929. (B) The time-
course of body temperature increase during exposure to hyperthermia did not differ 
between C57BL/6J and CSS2 mice, time F1,14 = 1704.63, P = 0.0001; time 9 group 
F1,14 = 1.363, P = 0.264. The time-course of body temperature increase during exposure 
to hyperthermia did not differ between C57BL/6J and CSS2 mice (time F1,14 = 1704.63, 
P = 0.0001; time 9 group F1,14 = 1.363, P = 0.264). Error Bars represents Standard Error 
of the Mean. The asterisk (*) denotes significant difference (P < 0.05). 
 
Fig. 2. QTL mapping on chromosome 2. (A) Frequency histogram of FS latencies of 
CSS2-F2 progeny (n = 143) shows that, as expected, the majority of these genetically 
unique CSS2-F2 mice have a shorter FSL than C57BL/6J (black bar is C57BL/6J 
average). (B) Identification of 2 FSL QTLs: QTL2a LOD = 3.6, (1-LOD support interval: 
52 581 428–66 278 629 bp) and QT2b LOD = 6.2, (1-LOD support interval: 114 875 
854–133 817 501 bp). 1-LOD support interval indicated with the dotted line (Cox et al., 
2009). 
 
Fig. 3. Homology between mouse QTL2A (left box) and a human chromosome 2 region 
(right box) containing the FEB3 locus (2q24) (Peiffer et al., 1999; Mantegazza et al., 
2005; Singh et al., 2009). Figure based on data derived from www.ensembl.org.  
Figure 1. 
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Supplemental Table 1  microsatelite markers chromosome 2  
 
  
 
 
